Selzentry

Active Ingredient(s): Maraviroc
FDA Approved: * August 6, 2007
Pharm Company: * PFIZER INC
Category: HIV / AIDS

Maraviroc, sold under the brand names Selzentry (US) and Celsentri (EU), is an antiretroviral drug in the CCR5 receptor antagonist class used in the treatment of HIV infection. It is also classed as an entry inhibitor. It also appeared to reduce graft-versus-host disease in patients treated with allogeneic bone marrow transplantation for leukemia, in a Phase I/II study.[5][6] Contents 1 Medical uses 2 Side effects 3 Mechanism of action 4 History 5 Names 6 See... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Selzentry Pfizer;MVC150
Selzentry 150 mg Oral Tablet
NDC: 49702-215
Labeler:
Viiv Healthcare Company
Selzentry Pfizer;MVC300
Selzentry 300 mg Oral Tablet
NDC: 49702-216
Labeler:
Viiv Healthcare Company
Selzentry MVC150
Selzentry 150 mg Oral Tablet
NDC: 49702-223
Labeler:
Viiv Healthcare Company
Selzentry MVC300
Selzentry 300 mg Oral Tablet
NDC: 49702-224
Labeler:
Viiv Healthcare Company
Selzentry MVC300
Selzentry 300 mg Oral Tablet, Film Coated
NDC: 50090-1486
Labeler:
A-s Medication Solutions
Selzentry MVC150
Selzentry 150 mg Oral Tablet
NDC: 52125-011
Labeler:
Remedyrepack Inc.
Selzentry MVC300
Selzentry 300 mg Oral Tablet, Film Coated
NDC: 54569-6214
Labeler:
A-s Medication Solutions
Selzentry 150 mg Oral Tablet
NDC: 0069-0807
Labeler:
Pfizer Laboratories Div Pfizer Inc
Selzentry 300 mg Oral Tablet
NDC: 0069-0808
Labeler:
Pfizer Laboratories Div Pfizer Inc
Selzentry 25 mg Oral Tablet, Film Coated
NDC: 49702-233
Labeler:
Viiv Healthcare Company
More Results